Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands

Bart Hoogveldt1, Benoît Rive2, Johan Severens3, Khaled Maman4, Chantal Guilhaume51Field Product Management, Lundbeck BV, Amsterdam, The Netherlands; 2Global Outcomes Research, Lundbeck SAS, Issy-les-Moulineaux, France; 3Institute of Health Policy and Management, Erasmus University Rott...

Full description

Bibliographic Details
Main Authors: Hoogveldt B, Rive B, Severens J, Maman K, Guilhaume C
Format: Article
Language:English
Published: Dove Medical Press 2011-06-01
Series:Neuropsychiatric Disease and Treatment
Online Access:http://www.dovepress.com/cost-effectiveness-analysis-of-memantine-for-moderate-to-severe-alzhei-a7658

Internet

http://www.dovepress.com/cost-effectiveness-analysis-of-memantine-for-moderate-to-severe-alzhei-a7658

Similar Items